NIH launches two trials to test blood thinners in Covid-19 patients
Is Inovio Stock a Buy Right Now? This Is What You Need to Know
A primer on viruses, vaccines, and therapies
Study takes us a step closer to a universal antibody test for COVID-19
AstraZeneca expects Covid vaccine result by year-end if trials resume
AstraZeneca Just Sneezed. Will Other Vaccine Makers Catch Cold?
Pfizer, BioNTech Set To Supply EU With 200M Covid-19 Vaccine Doses
Futures Rebound, Oil Jumps After Relentless 3-Day Hammering
AstraZeneca puts leading Covid-19 vaccine trial on hold over safety concern
AstraZeneca Shares Plunge As COVID Vaccine Study Put On Hold Due To "Adverse Reaction"
COVID19 vaccine makers’ pledge no better than NRA’s promises
3M awards philanthropic grant to Tel Aviv University for COVID-19 vaccine research
A Shot in the Arm
Cellular-level interactions that lead to the cytokine storm in COVID-19
Trump will not interfere with vaccine approval process, FDA chief reassures staff
MIT press first reads series continues with ‘Viruses, pandemics, and immunity’
How the government can drive medical innovation amidst the pandemic
Oxford scientists: these are final steps we're taking to get our coronavirus vaccine approved
Verona to test COPD hopeful ensifentrine in COVID-19 patients
Losing ground in COVID-19 vaccine race, CanSino turns to Russia
Early data shows Russia’s Sputnik V COVID-19 vaccine produces immune response
Digital success for pharma services in a uncertain world
Covid-19 vaccine developers prepare joint safety pledge: WSJ
Trump Vaccine Czar Says COVID-19 Vaccine By Election Day "Very, Very Unlikely"
Widespread Covid-19 vaccinations not expected until mid-2021, WHO says
Russia’s Covid-19 vaccine showed antibody response in initial trials
Steroids cut COVID-19 death rates, but not for everyone – here’s who benefits and who doesn’t
One Bank Warns The Coming Flu Season Could Lead To Chaos
Pfizer sees Covid-19 vaccine data in thick of U.S. election fight
Compass plans $100m IPO to fund magic mushroom depression drug